News

The study found that almost 8% of individuals aged two years and above had asthma, while more than half (52.3%) reported allergy symptoms.

The findings suggest that a multi-marker, multi-pathway approach can account for the heterogeneous ways HCC emerges.

The MAPLE-HCM trial shows aficamten improves exercise capacity and symptoms more than metoprolol in symptomatic obstructive hypertrophic cardiomyopathy.

In-hospital initiation of SGLT2 inhibitors is safe and may lower early cardiovascular death, worsening heart failure, and mortality in hospitalised patients.

To investigate the feasibility of RUTF for children with SCA, the SAMS trial in Nigeria enrolled 108 children aged five to twelve with severe acute malnutrition.

A new study suggests that the common cold may boost children’s antiviral defences, lowering the risk and severity of COVID-19.

A mobile health program significantly lowered blood pressure among users, with women—especially postmenopausal—showing greater improvements than men.

The POTCAST trial shows raising plasma potassium to high-normal levels reduces ventricular arrhythmia risk, hospitalisations, and death in ICD patients.